Good news … Chinese Sinopharm has developed an effective vaccine against the new Corona strain
China National Biotechnology Group chairman Yang Xiaoming said the efficacy of the vaccine developed by a unit of pharmaceutical giant Sinopharm showed good initial results against the new strain of the virus that emerged in Britain, according to Bloomberg News.
And the “Xinhua” News Agency quoted Yang as saying that clinical trials have shown that the doses volunteers receive between three or four weeks are the most effective.
Yang said data from clinical trials in the first and second stages shows the vaccine offers protection that can last for at least six months, noting that the group is waiting for the results to see if the vaccine offers protection that extends. over eight months.
Yang went on to say that the vaccine is safe and can be given to people aged 3 to 17, but called for caution in vaccinating children aged 3 to 5 as their immune systems are still developing.
Yang noted that China’s national biotechnology group could produce more than a billion doses of the vaccine in 2021.